In Leukemia and Lymphoma: Detection of Minimal Residual Disease,
hands-on experts describe and discuss the minimal residual disease
(MRD) methods they have successfully pioneered for leukemias and
lymphomas. They apply reverse transcription PCR (RT-PCR) to acute
myeloid leukemia (AML), chronic myelogenous leukemia (CML), and
acute promyelocytic leukemia (APL). Other PCR methods are used for
Non-Hodgkin's Lymphoma and for the monitoring of follicular
lymphoma. Additional chapters address the use of real-time
quantitative PCR (RQ-PCR), the emergent method of choice, in
patients with acute lymphoblastic leukemia (ALL), the evaluation of
MRD techniques in clinical trials, and the application of flow
cytometry techniques.
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!